{"id":"0e30cbad-5da8-48a3-bf7c-1dc4ec9496ad","name":"Multiply Labs","slug":"multiply-labs","description":"San Francisco-based robotics company building automated manufacturing systems for individualized drug and cell-therapy production. Founded in 2016 by Fred Parietti, [Multiply](/companies/multiply-labs) Labs raised 0M in Series A funding led by Casdin Capital to pioneer robotic manufacturing of individualized drugs, cutting costs and enabling personalized medicine at scale.","status":"private","founded":2016,"hq":"San Francisco, CA","hqLat":37.7879363,"hqLng":-122.4075201,"hqGeocodedAt":"2026-08-05T14:39:58.686Z","hqAddress":null,"hqPrecision":null,"website":"multiplylabs.com","fundingTotal":"20000000","type":"both","roles":["robot_operator"],"reviewStatus":"reviewed","heatIndex":77,"lifecycleState":"active","supersededByCompanyId":null,"sources":[{"url":"https://www.multiplylabs.com/"},{"url":"https://natlawreview.com/press-releases/multiply-labs-raises-75-million-series-b-close-gap-between-drug-discovery","title":"Multiply Labs Raises $75 Million Series B to Close the Gap Between Drug Discovery and Drug Manufacturing","sourceName":"Business Wire (via The National Law Review)","publishedAt":"2026-10-06"},{"url":"https://www.finsmes.com/2026/10/multiply-labs-raises-usd75m-in-series-b-funding.html","title":"Multiply Labs Raises USD75M in Series B Funding","sourceName":"FinSMEs","publishedAt":"2026-10-06"},{"url":"https://x.com/HealthcareAIGuy/status/2107521577558671755","title":"X post: health AI funding recap","sourceName":"X/@HealthcareAIGuy","publishedAt":"2026-10-06"}],"keyFacts":[{"label":"Focus","value":"Robotic automation systems for individualized drug and cell-therapy manufacturing."},{"label":"Series B (company-claimed)","value":"A $75 million Series B led by Dr. Patrick Soon-Shiong with NantWorks, announced Oct 6 2026, bringing total raised to over $100 million."},{"label":"Origins (company-claimed)","value":"Founded in 2016 as a Y Combinator startup; now calls itself a physical AI company automating biologics manufacturing."},{"label":"Investors (company-claimed)","value":"Oct 2026: New: AstraZeneca, Lingotto, Teradyne, Strange Ventures. Returning: Series A lead Casdin Capital, Lux Capital, Fifty Years, Ora Global, Founders Fund."},{"label":"Board (company-claimed)","value":"Oct 2026: Lingotto's Dr. Ileana Pirozzi joined the board."},{"label":"Deployment model (company-claimed)","value":"Robotic clusters plug into existing GMP processes and are owned and operated by the pharma customer. Customers are not named."},{"label":"Performance (company-claimed)","value":"A 74% reduction in cost per dose and up to 100 times the throughput of manual manufacturing."},{"label":"Expansion (company-claimed)","value":"Oct 2026: Expanding from cell and gene therapy to antibodies, viral vectors and mRNA."}],"aliases":["Multiply Labs Inc","Multiply Labs, Inc."],"collisionRisk":"low","reviewNote":null,"atsProvider":null,"atsSlug":null,"factoryLocations":null,"manufacturingCapacity":null,"orgType":null,"burnSignal":null,"litigationEvents":null,"insurancePostureDisclosed":null,"unitEconomicsDisclosed":null,"tickerSymbol":null,"stockExchange":null,"secCik":null,"revenueUsd":null,"revenueBasis":null,"revenueAsOf":null,"employeeCount":null,"employeeCountBasis":null,"employeeCountAsOf":null,"marketCapUsd":null,"marketCapAsOf":null,"marketCapSource":null,"createdAt":"2026-06-27T10:25:31.671Z","updatedAt":"2026-10-13T02:45:09.316Z","jsonLd":{"@context":"https://schema.org","@type":"Organization","@id":"https://registry.deploy.report/companies/multiply-labs","url":"https://registry.deploy.report/companies/multiply-labs","name":"Multiply Labs","alternateName":["Multiply Labs Inc","Multiply Labs, Inc."],"description":"San Francisco-based robotics company building automated manufacturing systems for individualized drug and cell-therapy production. Founded in 2016 by Fred Parietti, [Multiply](/companies/multiply-labs) Labs raised 0M in Series A funding led by Casdin Capital to pioneer robotic manufacturing of individualized drugs, cutting costs and enabling personalized medicine at scale.","identifier":"0e30cbad-5da8-48a3-bf7c-1dc4ec9496ad","foundingDate":"2016","address":"San Francisco, CA","publisher":{"@id":"https://deploy.report/#organization"}},"framework_metadata":{"framework_schema_version":"0.1.0","verification_status":"verified","maturity_stage":null,"lifecycle_state":null,"architectural_position":{"cohort":null,"sub_cohorts":[]},"within_cohort_verified_vs_claimed_pair":null,"cap_flags":[],"verification_depth":{"sources_count":4,"primary_source_types":[]}}}